Search

Author/Creator Shiu, Kai Keen

2. Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial. (March 2018)

Authors:
Adams, Richard; Brown, Ewan; Brown, Louise; Butler, Rachel; Falk, Stephen; Fisher, David; Kaplan, Richard; Quirke, Phil; Richman, Susan; Samuel, Leslie; Seligmann, Jenny; Seymour, Matt; Shiu, Kai Keen; Wasan, Harpreet; Wilson, Richard; Maughan, Tim
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 3:Number 3(2018)
Page Start:
162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search